Concept
Diabetes care cascade
The diabetes care cascade tracks how many people with diabetes are detected, treated, and controlled—and what programs or tools try to close those gaps across health systems.
Prevalence alone does not equal care. Students need separate claims for population cascade metrics, health-system program reviews, and single-app self-management trials.
Evidence
What the evidence shows
Drawn from 3 studies in this library. Each finding starts with a plain-language takeaway, then the denser detail. Supports means evidence for a finding; Challenges means evidence against a stated position; Qualifies marks scope with a short note on each study’s contribution. Challenged positions are labeled — they are not findings.
National STEPS data can show rising awareness while control stays low.
Iranian STEPS analyses found diabetes prevalence and awareness climbing, treatment peaking then dipping, and glycemic control remaining low—illustrating cascade leakage after detection.
- What’s being done for T2DM care across Africa?— multi-country program review — not the same national cascade measurement
Many countries run T2DM detection/adherence programs, but authors still judge them insufficient for rising burden.
A review of ongoing T2DM care activities highlights detection, monitoring, and adherence efforts amid obesity/urbanization drivers and HIV/TB co-morbidity, while arguing current efforts under-match need.
- Is Iran’s diabetes cascade improving over time?— one-country cascade metrics ≠ proof any listed program closed control gaps
Smartphone self-management tools are one narrow cascade lever, not a system fix.
A smartphone diabetes self-management application study for adults with type 1 diabetes tests digital support for day-to-day management rather than national awareness/treatment/control rates.
- Is Iran’s diabetes cascade improving over time?— app trial ≠ population effective coverage
Open questions
Tensions and limits
Some items are genuine disagreements on the same question. Others mark different assays, populations, or outcomes — limits on how far one study travels — not a forced fight between papers.
Awareness up, control still low in national survey vs Many programs exist but judged insufficient vs App-level self-management support in T1D
Common misconceptions
If awareness of diabetes rises, control must be rising too.
Cascade data can show awareness gains with persistently low control.
A successful app trial fixes national diabetes care.
Apps address self-management for selected users; cascades measure population detection/treatment/control.
Exam-style questions
Short-answer questions that ask you to explain or compare, not recall.
Name the usual diabetes care-cascade steps.
Prevalence/detection → awareness → treatment → control (effective coverage).
The studies
3 studies in this library bear on Diabetes care cascade, ordered by citations.
- Glucose Buddy app associated with improved type 1 HbA1c in a trial
Adults with poorly controlled type 1 diabetes using Glucose Buddy plus weekly educator texts lowered HbA1c versus usual care.
- What’s being done for T2DM care across Africa?
With ~19M adults with diabetes (→47M by 2045 if unchecked), African systems are expanding diagnosis/adherence programs—but major gaps remain, especially with HIV/TB co-morbidity.
- Is Iran’s diabetes cascade improving over time?
From 2004–2016 prevalence rose 8.4%→13.2% and awareness 53.5%→82.2%, but treatment (~36–46%) and control (~15–21%) stayed suboptimal.
Learn alongside
Change log
What changed
Dated edits to this page's evidence: studies added or removed from a claim, claims added or withdrawn, and new explanations tagged here. Rewordings are not listed.
- Concept page published